Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
Trial record 1 of 1 for:    NCT00982202
Previous Study | Return to List | Next Study

Pioglitazone in Alzheimer Disease

This study has been completed.
Sponsor:
Collaborator:
Takeda Pharmaceuticals North America, Inc.
Information provided by:
National Institute on Aging (NIA)
ClinicalTrials.gov Identifier:
NCT00982202
First received: September 22, 2009
Last updated: NA
Last verified: September 2009
History: No changes posted
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2005
  Primary Completion Date: January 2005 (Final data collection date for primary outcome measure)
No publications provided by National Institute on Aging (NIA)

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):